Shanghai RAAS Blood Products (002252.SZ) - EPS (earnings per share)

EPS in 2026 (TTM): A$0.07626

According to Shanghai RAAS Blood Products's latest financial reports the company's current EPS (TTM) is A$0.07171. In 2025 the company made an earnings per share (EPS) of A$0.04916 a decrease over its 2024 EPS that were of A$0.06480.

EPS history for Shanghai RAAS Blood Products from 2005 to 2026

Annual EPS

Year	EPS	Change
2026 (TTM)	A$0.07626	55.12%
2025	A$0.04916	-24.13%
2024	A$0.06480	18.38%
2023	A$0.05474	-5.91%
2022	A$0.05818	36.15%
2021	A$0.04273	-7.39%
2020	A$0.04614	87.44%
2019	A$0.02462	-138.11%
2018	A-$0.06459	-272.5%
2017	A$0.03745	-45.02%
2016	A$0.06810	5.85%
2015	A$0.06434	127.47%
2014	A$0.02829	48.29%
2013	A$0.01907	29.9%
2012	A$0.01468	13.1%
2011	A$0.01298	14.18%
2010	A$0.01137	40.49%
2009	A$0.008094	13.05%
2008	A$0.007160	18.08%
2007	A$0.006064	-37.8%
2006	A$0.009749	2.48%
2005	A$0.009512

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

EPS for Shanghai RAAS Blood Products (002252.SZ)